BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

476 related articles for article (PubMed ID: 2952797)

  • 21. Neuromuscular disorders associated with D-penicillamine treatment for rheumatoid arthritis.
    Devogelaer JP; Isaac G; Noël H; De Bruyère M; Huaux JP; Nagant de Deuxchaisnes C
    Int J Clin Pharmacol Res; 1985; 5(3):143-7. PubMed ID: 4018948
    [TBL] [Abstract][Full Text] [Related]  

  • 22. D-penicillamine-induced myasthenia gravis in rheumatoid arthritis.
    Froelich CJ; Hashimoto F; Searles RP; Bankhurst AD
    J Rheumatol; 1979; 6(2):237-9. PubMed ID: 458795
    [No Abstract]   [Full Text] [Related]  

  • 23. [Side effects of d-penicillamine in the treatment of rheumatoid arthritis].
    Mazzanti G; Paladini G; Damiani D; Bianchini D; Florean M; Mesesnel E; Cataldo R
    Minerva Med; 1986 May; 77(22-23):1009-16. PubMed ID: 2941698
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Myasthenia during treatment of rheumatoid polyarthritis with D-penicillamine].
    Carter H; Job-Deslandre C; Delrieu F; Menkes CJ
    Therapie; 1984; 39(6):689-95. PubMed ID: 6531741
    [No Abstract]   [Full Text] [Related]  

  • 25. A method of comparing the toxicities of disease suppressive agents: possible application to a comparison between D-penicillamine and chloroquine.
    Redda A; Anastassiades T
    Clin Invest Med; 1984; 7(1):65-71. PubMed ID: 6426836
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Penicillamine-induced myasthenia in chronic rheumatoid arthritis (author's transl)].
    Seitz D; Hopf HC; Janzen RW; Meyer W
    Dtsch Med Wochenschr; 1976 Jul; 101(31):1153-8. PubMed ID: 976101
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Penicillamine induced polymyositis and dermatomyositis.
    Carroll GJ; Will RK; Peter JB; Garlepp MJ; Dawkins RL
    J Rheumatol; 1987 Oct; 14(5):995-1001. PubMed ID: 3501473
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Initiation of myasthentic reactions by means of d-penicillamine (author's transl1].
    Rosenberger K; Winter H; Adams AE
    Nervenarzt; 1978 May; 49(5):277-81. PubMed ID: 673084
    [No Abstract]   [Full Text] [Related]  

  • 29. [Myasthenia induced by D-penicillamine during the treatment of rheumatoid polyarthritis].
    Carter H; Job-Deslandre C; Delrieu F; Kahan A; Menkès CJ
    Rev Rhum Mal Osteoartic; 1986 May; 53(5):341-4. PubMed ID: 3738397
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Penicillamine-induced pemphigus].
    Kind P; Goerz G; Gleichmann E; Plewig G
    Hautarzt; 1987 Sep; 38(9):548-52. PubMed ID: 3319968
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [D-penicillamine induced myasthenic syndromes in rheumatoid arthritis. Two cases (author's transl)].
    Rodat O; Hamelin JP; Rossard A; Cottin S; Cler JM; Rodat G; Lemouroux P
    Nouv Presse Med; 1981 May; 10(20):1645-8. PubMed ID: 7255126
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Penicillamine-induced ocular myasthenia gravis in rheumatoid arthritis.
    Liu GT; Bienfang DC
    J Clin Neuroophthalmol; 1990 Sep; 10(3):201-5. PubMed ID: 2144538
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Acetylcholine receptor antibody in D-penicillamine therapy].
    Kolarz G; Maida EM
    Z Rheumatol; 1986; 45(3):118-21. PubMed ID: 3751350
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical evaluation of D-penicillamine for the treatment of rheumatoid arthritis by a double blind test].
    Shiokawa Y; Horiuchi T; Honma M; Kageyama T; Okada T
    Ryumachi; 1977 Mar; 17(2):205-10. PubMed ID: 325668
    [No Abstract]   [Full Text] [Related]  

  • 35. [Undesirable effects of D-penicillamine in the therapy of rheumatoid arthritis].
    Trnavský K; Zbojanová M
    Fysiatr Revmatol Vestn; 1979 Apr; 57(2):87-91. PubMed ID: 570949
    [No Abstract]   [Full Text] [Related]  

  • 36. Selected adverse reactions of D-penicillamine.
    Stein HB; Chalmers A; Schroeder ML; Dillon A
    Clin Invest Med; 1984; 7(1):73-6. PubMed ID: 6723128
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Myasthenia gravis pseudoparalytica as a result of penicillamine treatment of rheumatoid arthritis].
    Gietka A
    Reumatologia; 1982; 20(1-2):65-8. PubMed ID: 7163666
    [No Abstract]   [Full Text] [Related]  

  • 38. [Long term treatment of rheumatoid arthritis. Experiences with D-penicillamine in comparison with gold and immunosuppressive drugs (author's transl)].
    Warnatz H; Scheiffarth F; Gutmann W
    Med Klin; 1975 Sep; 70(38):1509-15. PubMed ID: 810648
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The side effects of penicillamine therapy in rheumatoid arthritis.
    Huskisson EC
    J Rheumatol Suppl; 1981; 7():146-8. PubMed ID: 6939876
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Letter: Myasthenia and autoimmune thyroiditis during rheumatoid polyarthritis treated by D-penicillamine].
    Delrieu F; Menkes CJ; Sainte-Croix A; Delbarre F; Babinet P; Chesneau AM
    Nouv Presse Med; 1975 Nov; 4(40):2890(1). PubMed ID: 1215207
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.